Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association

Circulation. 2001 Oct 16;104(16):1985-91. doi: 10.1161/hc4101.096153.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / therapy
  • American Heart Association
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Contraindications
  • Disease Management
  • Glomerular Filtration Rate / drug effects
  • Heart / drug effects
  • Hemodynamics / drug effects
  • Humans
  • Hyperkalemia / etiology
  • Hyperkalemia / therapy
  • Hypertension / drug therapy*
  • Kidney / drug effects*
  • Plasma Volume
  • Renal Dialysis
  • Risk Factors
  • Thoracic Surgery

Substances

  • Angiotensin-Converting Enzyme Inhibitors